not tagged
not tagged
['sclc', 'nsclc']
top abstract #asco22 outcomes of first-line immune checkpoint inhibitors with or without chemotherapy according to kras mutational status and pd-l1 expression in patients with advanced nsclc: fda pooled analysis 
Vivek Subbiah, MD, (@VivekSubbiah) #PrecisionMedicine Expert and Medical Oncologist, takes over our Twitter today to discuss #ASCO22.